Surgery Partners (SGRY) reported a quarterly loss of $0.03 per share, beating the Zacks Consensus Estimate for a $0.15 loss by $0.12 per share. The result also improved versus earnings of $0.04 per share a year ago, indicating better-than-expected performance despite remaining in the red. The release is likely supportive for the stock but is not a major sector-level catalyst.
Surgery Partners (SGRY) reported a quarterly loss of $0.03 per share, beating the Zacks Consensus Estimate for a $0.15 loss by $0.12 per share. The result also improved versus earnings of $0.04 per share a year ago, indicating better-than-expected performance despite remaining in the red. The release is likely supportive for the stock but is not a major sector-level catalyst.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
